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Abstracts / Urological Science 26 (2015) 294e300 299the stone negative group. This prevalence rate in the ED population is
higher but not statistically different from previous study of the general
population of southern Taiwan. The average age, IIEF score, prevalence of
HTN, DM, dyslipidemia, smoking and obesity were compatible between
the two groups without difference. By contrast, 8 (38.1%) patients in the
stone positive group have low serum testosterone level, which is signiﬁ-
cant higher compared to 20 (12.1%) from the stone negative group
(P¼ 0.005).
Conclusions: In patients with ED, we found a higher incidence of stone
prevalence. For ED patients with urolithiasis, higher prevalence of low
serum testosterone level was found compared to those without uroli-
thiasis.
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COMPARISON OF THE POST-OPERATIVE INFECTION BY USING
DIFFERENT TYPE OF PROPHYLACTIC ANTIBIOTICS AND PLACEBO IN
HEALTHY ADULT PATIENTS WHO UNDERWENT URETERORENOSCOPIC
SURGERY
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Purpose: To compare the efﬁcacy of prophylactic antibiotics in reduction
of post-operative infections in patients undergoing ureterorenoscopy
(URS) as the intervention.
Materials and Methods: The study is a open-labeled, prospective, ran-
domized controlled trial. Between 2013 to 2014, 63 patients with preop-
erative sterile urine undergoing URS were randomly and equally allocated
by the randomization to three groups, and each group received prophy-
lactic antibiotics with single-dose intravenous cefazolin (1gm), oral
cefuroxime (500mg) or placebo (control group), respectively. The Urine
analysis and urine cultures were obtained around postoperative day 5 to 7.
We deﬁned pyuria as WBCS 10/HPF at urine sediment study, and signif-
icant bacteriuria was deﬁned as S105 CFU pathogens/ml in the urine..
Febrile urinary tract infection (fUTI) was deﬁned as body temperature
more than 38 Celsius degree with pyuria or signiﬁcant bacteriuria within 7
days post-operatively.
Results: Total 61 patients were recruited for the analysis. The post-
operative pyuriawere signiﬁcantly lower in patients with prophylaxis than
the placebo group. Patients receiving prophylactic antibiotics with cefa-
zolin and oral cefuroxime were subjected to signiﬁcantly lower risks of
pyuria compared with the control group (23.8% and 30% vs. 60.%, p<0.05).
There are the trends that the rate of bacteriuria was lower in patients
underwent prophylaxis, though it was not statistically signiﬁcant (12.2% vs
30%, p¼ 0.15) There was no signiﬁcant difference in rate of fUTI between
patients with abx prophylaxis and the placebo group. (1% vs. 0%, p¼ 1).
Conclusions: Antibiotic prophylaxis signiﬁcantly reduces the incidence of
pyuria following URSL and tends to decreased the risk of bacteriuria.
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Purpose: Endometriosis occurred in 10e15% of women of childbearing
age. Ureteral involvement is a rare manifestation of endometriosis and
occurs in only about 0.1% of women. The diagnosis is challenging since up
to 50% of patients are asymptomatic and may cause silent kidney or pro-
gressive renal function loss. There is no high evidence based treatment
protocol available currently. Literature is limited in case series and lapa-
roscopic resection of the endometriosis tissue seems to be the preferredmanagement now. Robotic-assisted management of ureteral endometri-
osis is a viable option but was scarcely reported. We reported 4 cases of
ureteral endometriosis with severe obstructive uropathy successful
treated by robotic-assisted segmental resection and ureteroureterostomy
or ureteroneocystostomy (RUU or RUC).
Materials and Methods: From January 2013 to September 2015, 3 women
received RUU and 1 woman received RUC due to ureteral endometriosis
related obstructive uropathy were reviewed.
Results:Mean agewas 36.25 year old (range 29e48), with mean follow-up
time 12.5 months (range 3e32). One patient was incidentally found to
have hydronephrosis, and 3 patients were initially presented with ipsi-
lateral ﬂank pain. All patients had normal serum creatinine (range
0.62e0.97mg/dl) preoperatively. Diagnosis was proved by MRI imaging.
The mean time of hydronephrosis to deﬁnitive treatment was 29.25
months (range 2e75). Left lower third ureter was involved in 3 patients,
right lower third ureter was involved in 1 patients. All 4 patients had
previous treatment failure by double-J stenting with or without medical
treatment. Pre-op ureteroscopy had been performed in all 4 patients, but
only 1 patient had endometriosis tissue invasion conﬁrmed by uretero-
scopic biopsy. Double-J stenting was performed for all the patients intra-
operatively and was removed 4e6 weeks after the operation. The proximal
and distal ureter cut ends were examined by frozen section during the
operation to ensure free of endometriosis tissue. Permanent pathology
reports all conﬁrmed endometrial glands in the ureteral wall. One patient
received myomectomy together, and another patient received hysterec-
tomy and left oopherectomy simultaneously. The mean blood loss was
132.5cc (range 30e250). No complication occurred. All patient received
diphereline treatment for 6 months after the operation. Follow-up so-
nography at post-op 3 months all showed resolves of hydronephrosis. Two
patients with follow-up of more than one year were free of
hydronephrosis.
Conclusion: Our experiences proved the feasibility and efﬁcacy of robotic-
assisted approach in this rare situation. The preliminary results seemed
promising and prospective patient enrollment is undergoing.
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Purpose: Symptoms of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
are often confused with uterine conditions. Gynecologists may therefore
recommend hysterectomy for these patients. We investigate if IC/BPS in-
creases the risk of hysterectomy in a large nationwide cohort study.
Materials and Methods: We performed a retrospective cohort study of
Longitudinal Health Insurance Database 2010 with newly diagnosis of fe-
male IC/BPS from 2002 through 2013. After limiting our sample to female
patients with IC/BPS diagnosis (ICD-9 code 595.1 at least once during the
study period), we identiﬁed the IC/BPS cohort. We then excluded female
patients who had been received hysterectomy (ICD-9 procedures codes,
68.4, 68.41, 68.49, 68.51, 68.59) before IC diagnosis. We deﬁned the logit of
predicted probability of hysterectomy as a propensity score using the
confounding factors including age and ﬁve comorbidities. Subjects with IC/
BPS were matched on a one-to-one basis with subjects without IC/BPS by
propensity score. The primary outcome was the event of hysterectomy
after the entry dates. The hazard ratio (HR) of hysterectomy in the IC/BPS
cohort was compared with the non-IC/BPS cohort by Cox regression after
adjusting for confounding factors.
Results: After matched by propensity score, we identiﬁed an IC/BPS cohort
with 1507 female subjects and a matched non-IC/BPS cohort with 1507
Abstracts / Urological Science 26 (2015) 294e300300female subjects. The hazard ratio (HR) of hysterectomy in non-IC/BPS
cohort compare with IC/BPS cohort is 2.932 (95% CI¼ 2.018-4.261,
p¼ .000) after controlling the age and ﬁve comorbidities by Cox regression
analysis
Conclusions: Our results imply us that the incidence of hysterectomy was
lower, instead of higher, in PBS/IC female patient after PBS/IC diagnosed in
these matched subjects. That is, PBS/IC is a protective factor of hysterec-
tomy for Taiwan female. The incidence of hysterectomy of PBS/IC female
patient before PBS/IC diagnosed should be further investigated to clarify
the relationship between PBS/IC and hysterectomy.
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LAPAROSCOPIC RADICAL PROSTATECTOMY IN OUR CENTER
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Purpose: In prostate cancer, very low-risk tumors are often managed well
with active surveillance, low to intermediate-risk tumors generally
respond well to localized treatment (surgery or radiation alone, brachy-
therapywith or without external-beam therapy). Intermediate to high-risk
tumors often require multimodal therapy (surgery with radiation, or ra-
diation therapy with hormonal therapy). All available treatments for
prostate cancer carry a risk of complications, side effects, and other im-
pacts to the patient's long-term quality of life. Therefore, some practice
suggested active surveillance in low-risk patient to avoid over treatment
and complication. However, new surgical technique and instrument
development, there can decrease surgical complication and improve pa-
tient outcome. We present the outcome of low-risk prostate cancer with
robotic-assisted laparoscopic radical prostatectomy (RALRP) in our
institution.
Materials and Methods: From April 2012 to August 2015, 128 male pa-
tients with prostate cancer underwent RALRP in Chi Mei Medical Center.
We follow the NCCN prostate cancer treatment guideline in our clinical
practice. Patient characteristics, DRE, PSA, Gleason score, preoperative
clinical staging, postoperative data and outcomes including ﬁnal patho-
logical staging, continence, potency, biochemical recurrence, post-
operative complications and surgical margins were analyzed.
Results: Only 7 patients are low risk group, the rest of 121 patients are
intermediate, high and very high risk group. The average age of the low
risk patients was 65.3 years (47~73). Pre-op mean PSA was 4.65 ng/ml
(1.8~5.59), only 2 patients had palpable hard nodule while DRE, Gleason
score were (3+3) in 6 patients and (2+2) in 1 patient. Post operation pa-
thology showed margin free in all 7 cases, but 4 patients up-staging to T2c,5 patients had total Gleason score 7 points and 6 patients shift to inter-
mediate risk group compare to pre-op evaluation. After 6 weeks of surgery,
PSA decrease to <0.01 ng/ml in all patient and during mean f/u times 19
months (9~33), no biochemical recurrence was noted.
Conclusion: Although pre-op are low-risk group, but we found that more
than half of the patient showed up-staging and up-grading after operation.
Due to the robotic assisted system development, less complication and
better outcome can be expected. May by operation can provided better
oncology outcome in low-risk prostate cancer patient.
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Purpose: Extracorporeal shock wave lithotripsy (ESWL), has been widely
performed in symptomatic renal and ureter stones especially renal pelvis
and upper ureter stone, with stone below 1.5 cm in size. Persist of non-
symptomatic renal stone without management, may induce intermittent
upper urinary tract infection which develop renal parenchymal injury and
subsequently scar formation follow by impair renal function.
Materials and Methods: A retrospective studies from Department of
Urology, Show Chwan Memorial Hospital.
A total of 133 patients whomwere collected from January 2013 to October
2015.
The patients have underwent ESWL intervention for renal and ureter
stone.
Long term stone impaction will induce recurrence urinary tract infection
and ﬁnally renal scarring if untreated. We would like to compare the pre-
ESWL and post-ESWL creatinine & eGFR data to predict whether regular
ESWL intervention can improve the renal function.
Results: From over studies, we found that 70.7% of patients have obtained
renal function improved after ESWL, whereas 29.3% patients had showed
functioning decline as well.
Conclusion: ESWL in renal stone intervention is either essential or
beneﬁcial for symptomatic patients with recurrence upper urinary tract
infection even in non-symptom and sign patients.
